Company / Net Debt per Share
Quest Diagnostics Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$46.47
FY2025
5-year range
$23.09 / $48.03
FY2021-FY2025
Trend
-3.3%
vs FY2024
Sector context
#14 of 98
Health Care
What the data says
Quest Diagnostics's net debt per share of $46.47 is higher than 86% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 10 years, ranging from $20.55 in FY2020 to $48.03 in FY2024.
Based on SEC 10-K filings.
46.47 in FY2025 with a 5-year CAGR of +17.7%. Top quartile in the Health Care sector.
Increased from $31.46 to $46.47 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +19.9%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -
Sector benchmark
+528.8% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 3.3% year-over-year.
- Ranks #14 out of 98 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2024.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.47 | -3.3% |
| FY2024 | $48.03 | +52.7% |
| FY2023 | $31.46 | +16.7% |
| FY2022 | $26.95 | +16.7% |
| FY2021 | $23.09 | +12.3% |
| FY2020 | $20.55 | -19.6% |
| FY2019 | $25.56 | -3.4% |
| FY2018 | $26.45 | +12.0% |
| FY2017 | $23.62 | -3.3% |
| FY2016 | $24.43 | +7.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026